IL17A and Alzheimer disease: While traditionally viewed as a primarily T helper type 2-mediated disease driven by cytokines like IL-4 and IL-13 [110,111], recent research indicates a more intricate immune landscape, with T helper 17 cells and their associated cytokines, particularly IL-17, also contributing to AD pathogenesis [112,113].